Abdullahi, A., Amini-Nik, S., and Jeschke, M. G. (2014). Animal models in burn research. Cell. Mol. Life Sci. 71, 3241–3255. doi:10.1007/s00018-014-1612-5
Ali, A. M., and Kunugi, H. (2021). Skeletal muscle damage in COVID-19: A call for action. Medicina 57, 372. doi:10.3390/medicina57040372
Ali, N. A., O’Brien, J. M., Jr, Hoffmann, S. P., Phillips, G., Garland, A., Finley, J. C., et al. (2008). Acquired weakness, handgrip strength, and mortality in critically ill patients. Am. J. Respir. Crit. Care Med. 178, 261–268. doi:10.1164/rccm.200712- 1829OC
Alves, C., MacDonald, T. L., Nigro, P., Pathak, P., Hirshman, M. F., Goodyear, L. J., et al. (2019). Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting. Biomed. Pharmacother. 117, 109197. doi:10.1016/j.biopha.2019.109197
Belizário, J. E., Fontes-Oliveira, C. C., Borges, J. P., Kashiabara, J. A., and Vannier, E. (2016). Skeletal muscle wasting and renewal: A pivotal role of myokine IL-6. SpringerPlus 5, 619. doi:10.1186/s40064-016-2197-2
Bharadwaj, U., Eckols, T. K., Xu, X., Kasembeli, M. M., Chen, Y., Adachi, M., et al. (2016). Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget 7, 26307–26330. doi:10.18632/oncotarget. 8368
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., et al. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704–1708. doi:10.1126/science.1065874
Bonetto, A., Aydogdu, T., Jin, X., Zhang, Z., Zhan, R., Puzis, L., et al. (2012). JAK/ STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am. J. Physiol. Endocrinol. Metab. 303, E410–E421. doi:10.1152/ajpendo.00039.2012
Bonetto, A., Aydogdu, T., Kunzevitzky, N., Guttridge, D. C., Khuri, S., Koniaris, L. G., et al. (2011). STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 6, e22538. doi:10.1371/journal. pone.0022538
Chandran, A., Hyder, A. A., and Peek-Asa, C. (2010). The global burden of unintentional injuries and an agenda for progress. Epidemiol. Rev. 32, 110–120. doi:10.1093/epirev/mxq009
Cohen, S., Nathan, J. A., and Goldberg, A. L. (2015). Muscle wasting in disease: Molecular mechanisms and promising therapies. Nat. Rev. Drug Discov. 14, 58–74. doi:10.1038/nrd4467
Corrick, K. L., Stec, M. J., Merritt, E. K., Windham, S. T., Thomas, S. J., Cross, J. M., et al. (2015). Serum from human burn victims impairs myogenesis and protein synthesis in primary myoblasts. Front. Physiol. 6, 184. doi:10.3389/fphys. 2015.00184
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., et al. (2004). Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest. 113, 115–123. doi:10.1172/JCI18330
Duan, H., Chai, J., Sheng, Z., Yao, Y., Yin, H., Liang, L., et al. (2009). Effect of burn injury on apoptosis and expression of apoptosis-related genes/proteins in skeletal muscles of rats. Apoptosis 14, 52–65. doi:10.1007/s10495-008-0277-7
Fanzani, A., Conraads, V. M., Penna, F., and Martinet, W. (2012). Molecular and cellular mechanisms of skeletal muscle atrophy: An update. J. Cachexia Sarcopenia Muscle 3, 163–179. doi:10.1007/s13539-012-0074-6
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., et al. (2015). The sick and the weak: Neuropathies/myopathies in the critically ill. Physiol. Rev. 95, 1025–1109. doi:10.1152/physrev.00028.2014
Fujinami, Y., Inoue, S., Ono, Y., Miyazaki, Y., Fujioka, K., Yamashita, K., et al. (2021). Sepsis induces physical and mental impairments in a mouse model of postintensive care syndrome. J. Clin. Med. 10, 1593. doi:10.3390/jcm10081593
Gavino, A. C., Nahmod, K., Bharadwaj, U., Makedonas, G., and Tweardy, D. J. (2016). STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model. Allergy 71, 1684–1692. doi:10.1111/all.12937
Glass, D. J. (2003). Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5, 87–90. doi:10.1038/ncb0203-87
Goodman, M. N. (1994). Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc. Soc. Exp. Biol. Med. 205, 182–185. doi:10.3181/00379727-205-43695
Gore, D. C., Wolf, S. E., Sanford, A. P., Herndon, D. N., and Wolfe, R. R. (2004). Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am. J. Physiol. Endocrinol. Metab. 286, E529–E534. doi:10.1152/ajpendo.00258. 2003
Guadagnin, E., Mazala, D., and Chen, Y. W. (2018). STAT3 in skeletal muscle function and disorders. Int. J. Mol. Sci. 19, 2265. doi:10.3390/ijms19082265
Haddad, F., Zaldivar, F., Cooper, D. M., and Adams, G. R. (2005). IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98, 911–917. doi:10.1152/japplphysiol. 01026.2004
Hart, D. W., Wolf, S. E., Ramzy, P. I., Chinkes, D. L., Beauford, R. B., Ferrando, A. A., et al. (2001). Anabolic effects of oxandrolone after severe burn. Ann. Surg. 233, 556–564. doi:10.1097/00000658-200104000-00012
Hermans, G., Van Mechelen, H., Clerckx, B., Vanhullebusch, T., Mesotten, D., Wilmer, A., et al. (2014). Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am.
J. Respir. Crit. Care Med. 190, 410–420. doi:10.1164/rccm.201312-2257OC Herndon, D. N., Ramzy, P. I., DebRoy, M. A., Zheng, M., Ferrando, A. A., Chinkes, D. L., et al. (1999). Muscle protein catabolism after severe burn: Effects of IGF-1/IGFBP-3 treatment. Ann. Surg. 229, 713–720. doi:10.1097/00000658- 199905000-00014 Hirata, Y., Nomura, K., Kato, D., Tachibana, Y., Niikura, T., Uchiyama, K., et al. (2022). A Piezo1/KLF15/IL-6 axis mediates immobilization-induced muscle atrophy. J. Clin. Invest. 132, 1–13. doi:10.1172/JCI154611 Huang, Z., Zhong, L., Zhu, J., Xu, H., Ma, W., Zhang, L., et al. (2020). PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways. Ann. Transl. Med. 8, 440. doi:10.21037/atm.2019.08.101
James, S. L., Lucchesi, L. R., Bisignano, C., Castle, C. D., Dingels, Z. V., Fox, J. T., et al. (2020). Epidemiology of injuries from fire, heat and hot substances: Global, regional and national morbidity and mortality estimates from the global burden of disease 2017 study. Inj. Prev. 26, i36–i45. doi:10.1136/injuryprev-2019-043299 Janssen, S. P., Gayan-Ramirez, G., Van den Bergh, A., Herijgers, P., Maes, K., Verbeken, E., et al. (2005). Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111, 996–1005. doi:10.1161/01.CIR.0000156469. 96135.0D
Kang, S., Tanaka, T., Inoue, H., Ono, C., Hashimoto, S., Kioi, Y., et al. (2020). IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc. Natl. Acad. Sci. U. S. A. 117 (36), 22351–22356. doi:10.1073/pnas.2010229117
Kashiwagi, S., Khan, M. A., Yasuhara, S., Goto, T., Kem, W. R., Tompkins, R. G., et al. (2017). Prevention of burn-induced inflammatory responses and muscle wasting by GTS-21, a specific agonist for α7 nicotinic acetylcholine receptors. Shock 47, 61–69. doi:10.1097/SHK.0000000000000729
Kazi, A. A., Pruznak, A. M., Frost, R. A., and Lang, C. H. (2011). Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesis. Shock 35, 117–125. doi:10.1097/SHK.0b013e3181ecb57c
Kim, J. B., Cho, Y. S., Jang, K. U., Joo, S. Y., Choi, J. S., and Seo, C. H. (2016). Effects of sustained release growth hormone treatment during the rehabilitation of adult severe burn survivors. Growth Horm. IGF Res. 27, 1–6. doi:10.1016/j.ghir.2015.12.009
Lang, C. H., Frost, R. A., Bronson, S. K., Lynch, C. J., and Vary, T. C. (2010). Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine. Am. J. Physiol. Endocrinol. Metab. 298, E1283–E1294. doi:10.1152/ajpendo.00676.2009
Lang, C. H., Frost, R. A., and Vary, T. C. (2004). Thermal injury impairs cardiac protein synthesis and is associated with alterations in translation initiation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R740–R750. doi:10.1152/ajpregu.00661. 2003
Lantos, J., Földi, V., Roth, E., Wéber, G., Bogár, L., and Csontos, C. (2010). Burn trauma induces early HMGB1 release in patients: Its correlation with cytokines. Shock 33, 562–567. doi:10.1097/SHK.0b013e3181cd8c88
Lewis, K. M., Bharadwaj, U., Eckols, T. K., Kolosov, M., Kasembeli, M. M., Fridley, C., et al. (2015). Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer. Lung Cancer 90, 182–190. doi:10.1016/j.lungcan.2015.09.014
Liang, F., Li, T., Azuelos, I., Giordano, C., Liang, H., Hussain, S. N., et al. (2018). Ventilator-induced diaphragmatic dysfunction in MDX Mice. Muscle Nerve 57, 442–448. doi:10.1002/mus.25760
Lin, B., Bai, L., Wang, S., and Lin, H. (2021). The association of systemic interleukin 6 and interleukin 10 levels with sarcopenia in elderly patients with chronic obstructive pulmonary disease. Int. J. Gen. Med. 14, 5893–5902. doi:10. 2147/IJGM.S321229
Liu, Z., Wang, C., Liu, X., and Kuang, S. (2018). Shisa2 regulates the fusion of muscle progenitors. Stem Cell Res. 31, 31–41. doi:10.1016/j.scr.2018.07.004
Medina, J. L., Fourcaudot, A. B., Sebastian, E. A., Shankar, R., Brown, A. W., and Leung, K. P. (2018). Standardization of deep partial-thickness scald burns in C57BL/6 mice. Int. J. Burns Trauma 8, 26–33.
Merritt, E. K., Cross, J. M., and Bamman, M. M. (2012). Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury. J. Burn Care Res. 33, 291–297. doi:10.1097/BCR.0b013e3182331e4b
Merritt, E. K., Thalacker-Mercer, A., Cross, J. M., Windham, S. T., Thomas, S. J., and Bamman, M. M. (2013). Increased expression of atrogenes and TWEAK family members after severe burn injury in nonburned human skeletal muscle. J. Burn Care Res. 34, e297–e304. doi:10.1097/BCR.0b013e31827a2a9c
Miao, C., Zhang, W., Feng, L., Gu, X., Shen, Q., Lu, S., et al. (2021). Cancerderived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia. Mol. Ther. Nucleic Acids 24, 923–938. doi:10.1016/j.omtn.2021.04.015
Mittal, A., Dua, A., Gupta, S., and Injeti, E. (2021). A research update: Significance of cytokine storm and diaphragm in COVID-19. Curr. Res. Pharmacol. Drug Discov. 2, 100031. doi:10.1016/j.crphar.2021.100031
Muñoz-Cánoves, P., Scheele, C., Pedersen, B. K., and Serrano, A. L. (2013). Interleukin-6 myokine signaling in skeletal muscle: A double-edged sword? Febs. J. 280, 4131–4148. doi:10.1111/febs.12338
Nakazawa, H., Chang, K., Shinozaki, S., Yasukawa, T., Ishimaru, K., Yasuhara, S., et al. (2017b). iNOS as a driver of inflammation and apoptosis in mouse skeletal muscle after burn injury: possible involvement of Sirt1 S-nitrosylation-mediated acetylation of p65 NF-κB and p53. PLoS One 12, e0170391. doi:10.1371/journal. pone.0170391
Nakazawa, H., Ikeda, K., Shinozaki, S., Kobayashi, M., Ikegami, Y., Fu, M., et al. (2017a). Burn-induced muscle metabolic derangements and mitochondrial dysfunction are associated with activation of HIF-1α and mTORC1: Role of protein farnesylation. Sci. Rep. 7, 6618. doi:10.1038/s41598-017-07011-3
Oh, D. Y., Lee, S. H., Han, S. W., Kim, M. J., Kim, T. M., Kim, T. Y., et al. (2015). Phase I study of OPB-31121, an oral STAT3 inhibitor, in patients with advanced solid tumors. Cancer Res. Treat. 47, 607–615. doi:10.4143/crt.2014.249
Ono, Y., Maejima, Y., Saito, M., Sakamoto, K., Horita, S., Shimomura, K., et al. (2020). TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice. Sci. Rep. 10, 694. doi:10. 1038/s41598-020-57714-3
Ono, Y., and Sakamoto, K. (2017). Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α. PLoS One 12, e0182040. doi:10.1371/journal.pone.0182040
Pelosi, M., De Rossi, M., Barberi, L., and Musaro, A. (2014). IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/ p70S6K axes, without affecting AKT activity. Biomed. Res. Int. 2014, 206026. doi:10.1155/2014/206026
Pereira, C., Murphy, K., Jeschke, M., and Herndon, D. N. (2005). Post burn muscle wasting and the effects of treatments. Int. J. Biochem. Cell Biol. 37, 1948–1961. doi:10.1016/j.biocel.2005.05.009
Pereira, C. T., Murphy, K. D., and Herndon, D. N. (2005). Altering metabolism. J. Burn Care Rehabil. 26, 194–199. doi:10.1097/01.BCR.0000162369.84374.18
Perry, B. D., Caldow, M. K., Brennan-Speranza, T. C., Sbaraglia, M., Jerums, G., Garnham, A., et al. (2016). Muscle atrophy in patients with type 2 diabetes mellitus: Roles of inflammatory pathways, physical activity and exercise. Exerc. Immunol. Rev. 22, 94–109.
Pileri, D., Accardo Palombo, A., D’Amelio, L., D’Arpa, N., Amato, G., Masellis, A., et al. (2008). Concentrations of cytokines IL-6 and IL-10 in plasma of burn patients: Their relationship to sepsis and outcome. Ann. Burns Fire Disasters 21, 182–185.
Pin, F., Bonetto, A., Bonewald, L. F., and Klein, G. L. (2019). Molecular mechanisms responsible for the rescue effects of pamidronate on muscle atrophy in pediatric burn patients. Front. Endocrinol. (Lausanne). 10, 543. doi:10.3389/fendo.2019.00543
Quintana, H. T., Bortolin, J. A., da Silva, N. T., Ribeiro, F. A., Liberti, E. A., Ribeiro, D. A., et al. (2015). Temporal study following burn injury in young rats is associated with skeletal muscle atrophy, inflammation and altered myogenic regulatory factors. Inflamm. Res. 64, 53–62. doi:10.1007/s00011-014-0783-8
Redell, M. S., Ruiz, M. J., Alonzo, T. A., Gerbing, R. B., and Tweardy, D. J. (2011). Stat3 signaling in acute myeloid leukemia: Ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor. Blood 117, 5701–5709. doi:10.1182/blood-2010-04-280123
Ribeiro, P. S., Jacobsen, K. H., Mathers, C. D., and Garcia-Moreno, C. (2008). Priorities for women’s health from the global burden of disease study. Int. J. Gynaecol. Obstet. 102, 82–90. doi:10.1016/j.ijgo.2008.01.025
Rupert, J. E., Narasimhan, A., Jengelley, D. H. A., Jiang, Y., Liu, J., Au, E., et al. (2021). Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J. Exp. Med. 218, e20190450. doi:10.1084/jem. 20190450
Saito, M., Fujinami, Y., Ono, Y., Ohyama, S., Fujioka, K., Yamashita, K., et al. (2021). Infiltrated regulatory T cells and Th2 cells in the brain contribute to attenuation of sepsis-associated encephalopathy and alleviation of mental impairments in mice with polymicrobial sepsis. Brain Behav. Immun. 92, 25–38. doi:10.1016/j.bbi.2020.11.010
Sala, D., and Sacco, A. (2016). Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases. Curr. Opin. Clin. Nutr. Metab. Care 19, 171–176. doi:10.1097/MCO.0000000000000273
Sartori, R., Romanello, V., and Sandri, M. (2021). Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease. Nat. Commun. 12, 330. doi:10. 1038/s41467-020-20123-1
Schiaffino, S., and Mammucari, C. (2011). Regulation of skeletal muscle growth by the IGF1-akt/PKB pathway: Insights from genetic models. Skelet. Muscle 1, 4. doi:10.1186/2044-5040-1-4
Sehat, A., Huebinger, R. M., Carlson, D. L., Zang, Q. S., Wolf, S. E., and Song, J. (2017). Burn serum stimulates myoblast cell death associated with IL-6-induced mitochondrial fragmentation. Shock 48, 236–242. doi:10.1097/SHK.0000000000000846
Seixas, M., Mitre, L. P., Shams, S., Lanzuolo, G. B., Bartolomeo, C. S., Silva, E. A., et al. (2022). Unraveling muscle impairment associated with COVID-19 and the role of 3D culture in its investigation. Front. Nutr. 9, 825629. doi:10.3389/fnut.2022.825629
Shelhamer, M. C., Rowan, M. P., Cancio, L. C., Aden, J. K., Rhie, R. Y., Merrill, G. A., et al. (2015). Elevations in inflammatory cytokines are associated with poor outcomes in mechanically ventilated burn patients. J. Trauma Acute Care Surg. 79, 431–436. doi:10.1097/TA.0000000000000786
Silva, K. A., Dong, J., Dong, Y., Dong, Y., Schor, N., Tweardy, D. J., et al. (2015). Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J. Biol. Chem. 290, 11177–11187. doi:10.1074/jbc.M115.641514
Siu, P. M., and Alway, S. E. (2005). Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle. J. Physiol. 565, 309–323. doi:10.1113/jphysiol. 2004.081083
Soares, M. N., Eggelbusch, M., Naddaf, E., Gerrits, K., van der Schaaf, M., van den Borst, B., et al. (2022). Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J. Cachexia Sarcopenia Muscle 13, 11–22. doi:10.1002/jcsm.12896
Song, J., Saeman, M. R., De Libero, J., and Wolf, S. E. (2015). Skeletal muscle loss is associated with TNF mediated insufficient skeletal myogenic activation after burn.
Shock 44, 479–486. doi:10.1097/SHK.0000000000000444 Supinski, G. S., and Callahan, L. A. (2006). Caspase activation contributes to endotoxin-induced diaphragm weakness. J. Appl. Physiol. 100, 1770–1777. doi:10. 1152/japplphysiol.01288.2005
Tam, B. T., Yu, A. P., Tam, E. W., Monks, D. A., Wang, X. P., Pei, X. M., et al. (2018). Ablation of Bax and Bak protects skeletal muscle against pressure-induced injury. Sci. Rep. 8, 3689. doi:10.1038/s41598-018-21853-5
Wada, E., Tanihata, J., Iwamura, A., Takeda, S., Hayashi, Y. K., and Matsuda, R. (2017). Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophindeficient mice. Skelet. Muscle 7, 23. doi:10.1186/s13395-017-0140-z
Wajant, H., Pfizenmaier, K., and Scheurich, P. (2003). Tumor necrosis factor signaling. Cell Death Differ. 10, 45–65. doi:10.1038/sj.cdd.4401189
Wang, W., Xu, C., Ma, X., Zhang, X., and Xie, P. (2020). Intensive care unitacquired weakness: A review of recent progress with a look toward the future. Front. Med. (Lausanne). 7, 559789. doi:10.3389/fmed.2020.559789
White, J. P., Puppa, M. J., Sato, S., Gao, S., Price, R. L., Baynes, J. W., et al. (2012). IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet. Muscle 2, 14. doi:10.1186/2044-5040-2-14
Wong, A. L., Soo, R. A., Tan, D. S., Lee, S. C., Lim, J. S., Marban, P. C., et al. (2015). Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies. Ann. Oncol. 26, 998–1005. doi:10.1093/annonc/mdv026
World Health Organization (2014). Injuries and violence: The facts 2014. Available at: https://apps.who.int/iris/bitstream/handle/10665/149798/ 9789241508018_eng.pdf (Accessed August 8, 2022).
Wu, X., Walters, T. J., and Rathbone, C. R. (2013). Skeletal muscle satellite cell activation following cutaneous burn in rats. Burns 39, 736–744. doi:10.1016/j.burns. 2012.10.016
Xu, X., Kasembeli, M. M., Jiang, X., Tweardy, B. J., and Tweardy, D. J. (2009). Chemical probes that competitively and selectively inhibit Stat3 activation. PLoS One 4, e4783. doi:10.1371/journal.pone.0004783
Yasuhara, S., Perez, M. E., Kanakubo, E., Yasuhara, Y., Shin, Y. S., Kaneki, M., et al. (2000). Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am. J. Physiol. Endocrinol. Metab. 279, E1114–E1121. doi:10. 1152/ajpendo.2000.279.5.E1114
Yousuf, Y., Jeschke, M. G., Shah, A., Sadri, A. R., Datu, A. K., Samei, P., et al. (2017). The response of muscle progenitor cells to cutaneous thermal injury. Stem Cell Res. Ther. 8, 234. doi:10.1186/s13287-017-0686-z
Zanders, L., Kny, M., Hahn, A., Schmidt, S., Wundersitz, S., Todiras, M., et al. (2022). Sepsis induces interleukin 6, Gp130/JAK2/STAT3, and muscle wasting. J. Cachexia Sarcopenia Muscle 13, 713–727. doi:10.1002/jcsm.12867
Zhang, G., Jin, B., and Li, Y. P. (2011). C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO. J. 30, 4323–4335. doi:10.1038/emboj.2011.292
Zhang, L., Pan, J., Dong, Y., Tweardy, D. J., Dong, Y., Garibotto, G., et al. (2013). Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 18, 368–379. doi:10.1016/j.cmet.2013.07.012
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., et al. (2010). Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531–543. doi:10.1016/j.cell.2010.07.011
論文の公開元へ
